Erratum: A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation
BMC Psychiatry
.
2014 Dec 10:14:313.
doi: 10.1186/s12888-014-0313-9.
Authors
Hideaki Katagiri
1
,
Shinji Fujikoshi
2
,
Takuya Suzuki
3
,
Kiyoshi Fujita
4
,
Naoya Sugiyama
5
,
Michihiro Takahashi
6
7
,
Juan-Carlos Gomez
8
Affiliations
1
Lilly Research Laboratories Japan, Eli Lilly Japan K.K, Kobe, Japan. katagiri_hideaki@lilly.com.
2
Lilly Research Laboratories Japan, Eli Lilly Japan K.K, Kobe, Japan. fujikoshi_shinji@lilly.com.
3
Ayase Hospital, 6-3-1 Ayase, Adachi-ku, Tokyo, 120-0005, Japan. takuya-s@pop01.odn.ne.jp.
4
Seishinkai Okehazama Hospital Fujita Kokoro Care Center, 3-879 Sakaecho Minamiyakata, Toyoake-shi, Aichi, 470-1168, Japan. kiyoshif@rg8.so-net.ne.jp.
5
Numazu Chuo Hospital, 24-1 Nakasecho, Numazu-shi, Shizuoka, 410-0811, Japan. naoyasug@numazuchuo.jp.
6
Lilly Research Laboratories Japan, Eli Lilly Japan K.K, Kobe, Japan. takahashi_michihiro@lilly.com.
7
Takahashi Psychiatric Clinic, Ashiya, Hyogo, Japan. takahashi_michihiro@lilly.com.
8
Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, 46285, USA. gomez_juan-carlos@lilly.com.
PMID:
25927447
PMCID:
PMC4260377
DOI:
10.1186/s12888-014-0313-9
No abstract available
Publication types
Published Erratum